AR022819A1 - PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION THAT UNDERSTAND AN ACTIVE PRINCIPLE OF THE BENZAMID FAMILY, AS WELL AS AT LEAST AN ABSORPTION ENGINEER - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION THAT UNDERSTAND AN ACTIVE PRINCIPLE OF THE BENZAMID FAMILY, AS WELL AS AT LEAST AN ABSORPTION ENGINEER

Info

Publication number
AR022819A1
AR022819A1 ARP000100941A ARP000100941A AR022819A1 AR 022819 A1 AR022819 A1 AR 022819A1 AR P000100941 A ARP000100941 A AR P000100941A AR P000100941 A ARP000100941 A AR P000100941A AR 022819 A1 AR022819 A1 AR 022819A1
Authority
AR
Argentina
Prior art keywords
well
pharmaceutical compositions
family
absorption
benzamid
Prior art date
Application number
ARP000100941A
Other languages
Spanish (es)
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of AR022819A1 publication Critical patent/AR022819A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones farmacéuticas que comprenden un principio activo de la familia de las benzamidas, así como por lo menos un promotor de absorcion que puedeser un inhibidor de la P-glicoproteína.Pharmaceutical compositions comprising an active substance of the benzamide family, as well as at least one absorption promoter that can be a P-glycoprotein inhibitor.

ARP000100941A 1999-03-04 2000-03-03 PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION THAT UNDERSTAND AN ACTIVE PRINCIPLE OF THE BENZAMID FAMILY, AS WELL AS AT LEAST AN ABSORPTION ENGINEER AR022819A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9902680A FR2790388B1 (en) 1999-03-04 1999-03-04 PHARMACEUTICAL COMPOSITIONS COMPRISING A BENZAMIDE AND AT LEAST ONE ABSORPTION PROMOTER

Publications (1)

Publication Number Publication Date
AR022819A1 true AR022819A1 (en) 2002-09-04

Family

ID=9542809

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100941A AR022819A1 (en) 1999-03-04 2000-03-03 PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION THAT UNDERSTAND AN ACTIVE PRINCIPLE OF THE BENZAMID FAMILY, AS WELL AS AT LEAST AN ABSORPTION ENGINEER

Country Status (9)

Country Link
JP (1) JP2002538094A (en)
AR (1) AR022819A1 (en)
AU (1) AU2922800A (en)
CA (1) CA2362480A1 (en)
CO (1) CO5440229A1 (en)
FR (1) FR2790388B1 (en)
PE (1) PE20001554A1 (en)
UY (1) UY26050A1 (en)
WO (1) WO2000051563A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2857263B1 (en) * 2003-07-09 2005-09-09 Sanofi Synthelabo NOVEL SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMISULPRIDE
AR071375A1 (en) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh FORMULATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF DEFICIENT PERMEABILITY, PREPARATION AND PRODUCT PROCESS
CN101507432B (en) * 2009-04-02 2012-12-19 河北省林业科学研究院 Carvacrol micro-emulsion and production technique thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8605515D0 (en) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION OF A PHARMACEUTICALLY ACTIVE SUBSTANCE
EP0303445A1 (en) * 1987-08-13 1989-02-15 Walton S.A. Clebopride transdermal patch
JPH01236980A (en) * 1988-03-14 1989-09-21 Iseki & Co Ltd Storage tank equipped with small rice grain sieving device
FR2753376B1 (en) * 1996-09-18 1998-10-16 Synthelabo PHARMACEUTICAL COMPOSITIONS COMPRISING AMISULPRIDE AND THERAPEUTIC APPLICATIONS THEREOF
FR2762213B1 (en) * 1997-04-18 1999-05-14 Synthelabo PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION

Also Published As

Publication number Publication date
UY26050A1 (en) 2000-09-29
CO5440229A1 (en) 2004-09-30
FR2790388A1 (en) 2000-09-08
PE20001554A1 (en) 2001-03-18
CA2362480A1 (en) 2000-09-08
FR2790388B1 (en) 2001-04-13
JP2002538094A (en) 2002-11-12
AU2922800A (en) 2000-09-21
WO2000051563A1 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
AR033423A1 (en) PHARMACEUTICAL SALTS CONSTITUTED OF AN ACTIVE PHARMACEUTICAL SUBSTANCE AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS AND USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES
ES2156603T3 (en) MEDICATIONS BASED ON A SYNTHETIC MIXTURE OF METRONIDAZOL AND CLINDAMYCIN.
PT1300398E (en) PROCESSES AND COMPOSITIONS FOR CANCER THERAPIES, USING GENES THAT CODE THE BETA INTERFERENCE
ECSP055582A (en) BENZOTIAZOL DERIVATIVES THAT HAVE BETA-2-ADRENORRECEPTOR AGONIST ACTIVITY
BRPI0415121A (en) particulate material, solid dosage form, method of manufacturing it, and use of a particulate material or solid dosage form
ES2184293T3 (en) ADMINISTRABLE PHARMACEUTICAL COMPOSITIONS BY ORAL ROUTE THAT INCLUDE A BENZHYDR-PIPERAZINE AND A CYCLODEXTRINE.
GT199900203A (en) CELECOXIB COMPOSITIONS.
AR019690A1 (en) PHARMACEUTICAL FORMULATION FOR AEROSOLS WITH TWO OR MORE ACTIVE SUBSTANCES
BR0306870A (en) Oral pharmaceutical composition and method for preparing the same
HN2002000247A (en) SULFONAMIDE DERIVATIVES
BRPI0417072A (en) preventive agent for vasculitis
PT750618E (en) OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
MX9202407A (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ALYLAMINE COMPOUND AS THE ACTIVE AGENT AND PROCESS FOR ITS PREPARATION.
PE20020307A1 (en) HYDROGEL ACTIVATED DRUG DOSAGE FORM
CU23346A3 (en) AMICARBAZONA BASED HERBICIDES
HRP20050510A2 (en) Microbicide substances
MXPA06011467A (en) Active substance combination comprising a carbinol combined to at least an nsaid.
DK1526839T3 (en) Oral pharmaceutical forms of liquid drugs with improved bioavailability
MX2007008227A (en) Prevention of thrombotic disorders with active vitamin d compounds or mimics thereof.
CY1108676T1 (en) Ophthalmic suspension comprising an ophthalmic drug, a poloxamine AND AN AGENT REGULATION OF TONIKOTITAS TYPE GLYKOLIS, USE OF SAID COMPOSITION FOR THE PRODUCTION OF A medicament for treating ophthalmic disorders
ECSP078057A (en) FORMULATIONS OF CONJUGATED ESTROGENS AND BAZEDOXIFEN
AR110174A2 (en) ENDOPARASITICID AGENTS AND PREPARATION PROCEDURE
NO20064808L (en) Oral matrix formulations with licarbazepine
PT1121127E (en) PHARMACEUTICAL COMPOSITIONS ORAIS CONTAINING BUPRENORFIN
PA8532001A1 (en) USEFUL BIFENYL CARBOXAMIDS AS LIPID REDUCING AGENTS